| A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia T Herold, V Jurinovic, AMN Batcha, SA Bamopoulos, ... haematologica 103 (3), 456, 2018 | 103 | 2018 |
| Evolution of cytogenetically normal acute myeloid leukemia during therapy and relapse: an exome sequencing study of 50 patients PA Greif, L Hartmann, S Vosberg, SM Stief, R Mattes, I Hellmann, ... Clinical cancer research 24 (7), 1716-1726, 2018 | 83 | 2018 |
| The clinical mutatome of core binding factor leukemia S Opatz, SA Bamopoulos, KH Metzeler, T Herold, B Ksienzyk, K Bräundl, ... Leukemia 34 (6), 1553-1562, 2020 | 67 | 2020 |
| ZBTB7A mutations in acute myeloid leukaemia with t (8; 21) translocation L Hartmann, S Dutta, S Opatz, S Vosberg, K Reiter, G Leubolt, ... Nature communications 7 (1), 11733, 2016 | 60 | 2016 |
| Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia SA Bamopoulos, AMN Batcha, V Jurinovic, M Rothenberg-Thurley, ... Leukemia 34 (10), 2621-2634, 2020 | 47 | 2020 |
| NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer J Doffo, SA Bamopoulos, H Köse, F Orben, C Zang, M Pons, ... Proceedings of the National Academy of Sciences 119 (9), e2105691119, 2022 | 20 | 2022 |
| Allelic imbalance of recurrently mutated genes in acute myeloid leukaemia AMN Batcha, SA Bamopoulos, P Kerbs, A Kumar, V Jurinovic, ... Scientific reports 9 (1), 11796, 2019 | 14 | 2019 |
| Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid … R Hornung, V Jurinovic, AMN Batcha, SA Bamopoulos, ... Scientific Reports 8 (1), 11293, 2018 | 13 | 2018 |
| SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma GJJE Heynen, F Baumgartner, M Heider, U Patra, M Holz, J Braune, ... Blood Advances 7 (4), 469-481, 2023 | 7 | 2023 |
| Authentication of primary murine cell lines by a microfluidics-based lab-on-chip system Y Hong, N Singh, S Bamopoulos, E Gjerga, LK Schmalbrock, ... Biomedicines 8 (12), 590, 2020 | 4 | 2020 |
| Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022 F Baumgartner, C Baer, S Bamopoulos, E Ayoub, M Truger, ... Blood 143 (12), 1139-1156, 2024 | 1 | 2024 |
| Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity F Baumgartner, SA Bamopoulos, L Faletti, HJ Hsiao, M Holz, ... Science Signaling 17 (824), eadc9662, 2024 | | 2024 |
| Risk Stratification of Patients with RUNX1-mutated Acute Myeloid Leukemia C Rausch, R Hornung, A Batcha, M Rothenberg-Thurley, SA Bamopoulos, ... Blood 142 (Supplement 1), 2934-2934, 2023 | | 2023 |
| Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML AMN Batcha, N Buckup, SA Bamopoulos, V Jurinovic, ... Blood advances 7 (6), 1040-1044, 2023 | | 2023 |
| Die Kombination mit einem first-in-class SUMOylierungs inhibitor uberwindet die Resistenz gegenuber Proteasom-Inhibitoren beim Multiplen Myelom GJ Heynen, F Baumgartner, M Heider, U Patra, M Holz, M Kaiser, ... | | 2022 |
| Differential splicing and allelic imbalance as pathomechanisms of recurring mutations in Acute Myeloid Leukemia SA Bamopoulos lmu, 2021 | | 2021 |
| Authentication of primary murine immortalized hematopoietic progenitor cell lines by a microfluidics-based lab-on-a-chip system Y Hong, N Nikita, S Bamopoulos, E Gjerga, LK Schmalbrock, M Schick, ... ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 236-236, 2020 | | 2020 |
| Clinical presentation and differential splicing ofSRSF2, U2AF1andSF3B1mutations in patients with Acute Myeloid Leukaemia SA Bamopoulos, AMN Batcha, V Jurinovic, M Rothenberg-Thurley, ... | | 2020 |
| PF210 CLINICAL ASPECTS AND DIFFERENTIAL SPLICING IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SRSF2, U2AF1 AND SF3B1 MUTATIONS S Bamopoulos, A Batcha, V Jurinovic, M Rothenberg‐Thurley, H Janke, ... HemaSphere 3, 57, 2019 | | 2019 |
| Synergistic effect of inhibition of multiple PI3K-isoforms due to the differential mode of action of single PI3K-isoform inhibitors in mantle cell lymphoma G Hutter, Y Zimmermann, SA Bamopoulos, M Irger, W Hiddemann, ... ONCOLOGY RESEARCH AND TREATMENT 40, 154-154, 2017 | | 2017 |
